Disabling pansclerotic morphoea: A case report

International Journal of Clinical Practice

Volumn 64, Issue 1, 2010, Pages 99-101

  Tekin, N S ^a   Altinyazar, H C ^a   Tekin, I O ^a   Keskin, S I ^a   Kucukoglu, R ^b   Onsun, N ^c  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; EMOLLIENT AGENT; NARCOTIC ANALGESIC AGENT; TRIAMCINOLONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC WOUND; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAGOPHTHALMOS; MORPHEA; OSTEOMYELITIS; PAIN; PANSCLEROTIC MORPHEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SCLEROSIS; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS INFECTION; WOUND CARE;

ADULT; AMPUTATION; DISABLED PERSONS; FATAL OUTCOME; FEMALE; HUMANS; SCLERODERMA, LOCALIZED;

EID: 72449164506     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01039.x     Document Type: Article

References (14)

1. Diaz-Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children. Arch Dermatol 1980 116 : 169 173.
2. Maragh SH, Davis MD, Bruce AJ, Nelson AM. Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol 2005 53 (2 Suppl. 1 S115 9.
3. Wollina U, Looks A, Uhlemann C, Wollina K. Pansclerotic morphea of childhood-follow-up over 6 years. Pediatr Dermatol 1999 16 : 245 247.
4. Doede T, Wollina U, Hindermann W, Schier F, Bondartschuk M. Pansclerotic morphea in childhood: a case report. Pediatr Surg Int 2003 19 : 406 408.
5. Devidayal Singh S, Kumar L, Radotra BD. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association. Rheumatol Int 2002 21 : 158 160.
6. Doede T, Wollina U, Hindermann W, Schier F, Bondartschuk M. Pansclerotic morphea in childhood: a case report. Pediatr Surg Int 2003 19 : 406 408.
7. Stucker M, Schreiber D, Gruss C et al. Severe course of a mutilating pansclerotic circumscribed scleroderma in childhood. Clinical aspects and therapy. Hautarzt 1999 50 : 131 135 (in German).
8. Bielefeld P. Systemic scleroderma and malignant diseases: a review of the literature. Rev Med Interne 1991 12 : 350 354 (in French).
9. Wollina U, Buslau M, Weyers W. Squamous cell carcinoma in pansclerotic morphea of childhood. Pediatr Dermatol 2002 19 : 151 154.
10. Parodi PC, Riberti C, Draganic Stinco D, Patrone P, Stinco G. Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea. Br J Dermatol 2001 144 : 417 419.
11. Hatamochi A, Ono M, Arakawa M, Takeda K, Ueki H. Analysis of collagen gene expression by cultured fibroblasts in morphoea. Br J Dermatol 1992 126 : 216 221.
12. Gruss C, Stucker M, Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997 136 : 293 294.
13. Todd DJ, Askari A, Ektaish E. PUVA therapy for disabling pansclerotic morphoea of children. Br J Dermatol 1998 138 : 201 202.
14. Yildirim M, Baysal V, Aridogan BC, Kesici D, Erturan I. Pansclerotic morphea treated with UVA: a case report. J Dermatol 2003 30 : 625 627.